NCT00334412View on ClinicalTrials.gov

COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

May 31, 2006

Conditions
Invasive Aspergillosis
Interventions
DRUG

Ambisome

DRUG

caspofungin

Trial Locations (1)

75015

Gilead Sciences, Paris

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY